睿智医药：9月8日召开董事会会议

Group 1 - The company, Ruizhi Pharmaceutical, announced that its sixth board meeting was held on September 8, 2025, to discuss financing lease guarantees and related transactions [1] - For the first half of 2025, the revenue composition of Ruizhi Pharmaceutical was as follows: 99.06% from pharmaceutical research and development services and production outsourcing, 0.52% from prebiotic series, 0.35% from rental income, and 0.07% from other industries [1] - As of the report date, the market capitalization of Ruizhi Pharmaceutical was 6.8 billion yuan [1] Group 2 - The article highlights a significant shift in the perception of Chinese data by multinational pharmaceutical companies, indicating a breakthrough in China's innovative drug sector [1]